
Hans-Olov Adami, M.D. Ph.D.
Professor, Department of Epidemiology, Harvard School Of Public Health
Department Chair, Epidemiology, Harvard School Of Public Health
Contact Info
Hans-Olov Adami
Harvard School Of Public Health
677 Huntington Avenue
Boston, MA, 02115
Mailstop: 904 Kresge
Phone: 617-432-6477
Fax: 617-566-7805
hadami@hsph.harvard.edu
Administrative Assistant
Epidemiology
Harvard School Of Public Health
677 Huntington Avenue
Boston, MA, 02115
Phone: 617-432-6477
Fax: 617-566-7805
dhavelic@hsph.harvard.edu
Rachel L Axelbank
Administrative Assistant
Department of Epidemiology
Harvard School Of Public Health
651 Huntington Avenue
Boston, MA, 02115
Phone: 617-432-4239
raxelban@hsph.harvard.edu
Harvard School Of Public Health
677 Huntington Avenue
Boston, MA, 02115
Mailstop: 904 Kresge
Phone: 617-432-6477
Fax: 617-566-7805
hadami@hsph.harvard.edu
Assistant
David HavelickAdministrative Assistant
Epidemiology
Harvard School Of Public Health
677 Huntington Avenue
Boston, MA, 02115
Phone: 617-432-6477
Fax: 617-566-7805
dhavelic@hsph.harvard.edu
Rachel L Axelbank
Administrative Assistant
Department of Epidemiology
Harvard School Of Public Health
651 Huntington Avenue
Boston, MA, 02115
Phone: 617-432-4239
raxelban@hsph.harvard.edu
DF/HCC Program Affiliation
Prostate CancerCancer Epidemiology
DF/HCC Associations
Associate Director, Population Science, Executive CommitteeDirector, Rapid Case Identification
Member, Center Scientific Council
Research Abstract
With a long background as a practicing surgeon with a focus on oncology, I have always conducted clinical and epidemiologic research in parallel. My clinical research includes randomized trials, prognostic studies, and studies of clinical issues using an observational study design. Over the years, however, my focus has been on cancer epidemiology, and I have worked on a large number of cancer sites and types. Currently, I am working predominantly on prostate cancer, (with research ranging from genetic association studies to randomized trials of radical surgical treatment, and prediction of outcome using molecular and genetic markers), malignant lymphomas, cervical cancer (with a focus on viral load as a possible determinant of progression from precursors to invasive cancer), and breast cancer. I am also involved in planning a large prospective cohort study in Sweden, and integrating this with other similar initiatives around the globe.Publications
- Schollkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B, Chang ET, Roos G, Hansen M, Adami HO, Hjalgrim H.Borrelia infection and risk of non-Hodgkin lymphoma.Blood 2008 Apr 18.
18424667 - Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, Beeson WL, van den Brandt PA, Buring JE, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Lacey JV Jr, Leitzmann M, Lukanova A, Marshall JR, Miller AB, Patel AV, Rodriguez
18381473 - Mink PJ, Adami HO, Trichopoulos D, Britton NL, Mandel JS.Pesticides and prostate cancer: a review of epidemiologic studies with specific agricultural exposure information.Eur J Cancer Prev 2008 Apr;17(2):97-110.
18287866 - Schollkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Panum I, Vinner L, Chang ET, Glimelius B, Porwit A, Sundstrom C, Hansen M, Adami HO, Melbye M.Hepatitis C infection and risk of malignant lymphoma.Int J Cancer 2008 Apr 15;122(8):1885-90.
18271005 - Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorlei
18264098 - Olsson M, Lindstrom S, Haggkvist B, Adami HO, Balter K, Stattin P, Ask B, Rane A, Ekstrom L, Gronberg H.The UGT2B17 gene deletion is not associated with prostate cancer risk.Prostate 2008 Apr 1;68(5):571-5.
18247404 - Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Gronberg H.Cumulative association of five genetic variants with p
18199855 - Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrén O, Eisenstein AS, Holmberg L, Huang W, Kantoff PW, Perner S, Stampfer MJ, Johansson JE, Rubin MA.Nine-gene molecular signature is not associated with prostate cancer death
18199732 - Troisi R, Lagiou P, Trichopoulos D, Xu B, Chie L, Stanczyk FZ, Potischman N, Adami HO, Hoover RN, Hsieh CC.Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonat
18199728 - Ioannidis JP, Adami HO.Nested randomized trials in large cohorts and biobanks: studying the health effects of lifestyle factors.Epidemiology 2008 Jan;19(1):75-82.
18090999 - Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Balter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Pa
18073375 - Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F.Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.Journal of the Nationa
18073376 - Trichopoulos D, Adami HO, Ekbom A, Hsieh CC, Lagiou P.Early life events and conditions and breast cancer risk: from epidemiology to etiology.Int J Cancer 2008 Feb 1;122(3):481-5.
18022897 - Smedby KE, Hjalgrim H, Chang ET, Rostgaard K, Glimelius B, Adami HO, Melbye M.Childhood social environment and risk of non-Hodgkin lymphoma in adults.Cancer Res 2007 Nov 15;67(22):11074-82.
18006854 - Czene K, Adami HO, Chang ET.Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma.Cancer Epidemiol Biomarkers Prev 2007 Nov;16(11):2496-9.
18006943 - Baik I, Lambe M, Liu Q, Cnattingius S, Mucci LA, Riman T, Ekbom A, Adami HO, Hsieh CC.Gender of offspring and maternal risk of invasive epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev 2007 Nov;16(11):2314-20.
18006920 - Luo J, Adami HO, Reilly M, Ekbom A, Nordenvall C, Ye W.Interpreting trends of pancreatic cancer incidence and mortality: a nation-wide study in Sweden (1960-2003).Cancer Causes Control 2008 Feb;19(1):89-96.
17943451 - Gram IT, Braaten T, Adami HO, Lund E, Weiderpass E.Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer.Int J Cancer 2008 Feb 1;122(3):647-52.
17918152 - Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH, Hallmans G, Balter K, Adami HO, Gronberg H, Stattin P, Kaaks R.Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels.J C
17911177 - Hartman M, Lindstrom L, Dickman PW, Adami HO, Hall P, Czene K.Is breast cancer prognosis inherited?.Breast Cancer Res 2007 Jun 28;9(3):R39.
17598882 - Fall K, Garmo H, Andrén O, Bill-Axelson A, Adolfsson J, Adami HO, Johansson JE, Holmberg L,.Prostate-specific antigen levels as a predictor of lethal prostate cancer.J Natl Cancer Inst 2007 Apr 4;99(7):526-32.
17405997 - Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D.Multiple myeloma: a review of the epidemiologic literature.Int J Cancer 2007;120 Suppl 12:40-61.
17405120 - Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D.The non-Hodgkin lymphomas: a review of the epidemiologic literature.Int J Cancer 2007;120 Suppl 12:1-39.
17405121 - Melbye M, Smedby KE, Lehtinen T, Rostgaard K, Glimelius B, Munksgaard L, Schöllkopf C, Sundström C, Chang ET, Koskela P, Adami HO, Hjalgrim H.Atopy and risk of non-Hodgkin lymphoma.J Natl Cancer Inst 2007 Jan 17;99(2):158-66.
17227999 - McKay JD, Kaaks R, Johansson M, Biessy C, Wiklund F, Bälter K, Adami HO, Boillot C, Gioia-Patricola L, Canzian F, Stattin P, Grönberg H.Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.Cancer Epidem
17220348 - Johansson M, McKay JD, Stattin P, Canzian F, Boillot C, Wiklund F, Adami HO, Bälter K, Grönberg H, Kaaks R.Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.Int J Cancer 2007 Feb 1;120(3):539-42.
17096324




